Envveno Medical Corp Stock Buy Hold or Sell Recommendation
| NVNO Stock | USD 3.53 0.04 1.15% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding enVVeno Medical Corp is 'Strong Sell'. The recommendation algorithm takes into account all of EnVVeno Medical's available fundamental, technical, and predictive indicators you will find on this site.
Check out EnVVeno Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as EnVVeno and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
EnVVeno |
Execute EnVVeno Medical Buy or Sell Advice
The EnVVeno recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on enVVeno Medical Corp. Macroaxis does not own or have any residual interests in enVVeno Medical Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EnVVeno Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
EnVVeno Medical Trading Alerts and Improvement Suggestions
| enVVeno Medical Corp had very high historical volatility over the last 90 days | |
| Net Loss for the year was (23.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| enVVeno Medical Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: enVVeno Medical Participates in the Virtual Investor Top 5 for 25 On-Demand Conference |
EnVVeno Medical Returns Distribution Density
The distribution of EnVVeno Medical's historical returns is an attempt to chart the uncertainty of EnVVeno Medical's future price movements. The chart of the probability distribution of EnVVeno Medical daily returns describes the distribution of returns around its average expected value. We use enVVeno Medical Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EnVVeno Medical returns is essential to provide solid investment advice for EnVVeno Medical.
| Mean Return | 0.04 | Value At Risk | -5.59 | Potential Upside | 8.51 | Standard Deviation | 4.04 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EnVVeno Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
EnVVeno Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as EnVVeno Medical, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading enVVeno Medical Corp back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Hohimer Wealth Management, Llc | 2024-12-31 | 51.3 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 48.8 K | Squarepoint Ops Llc | 2024-12-31 | 47.9 K | State Street Corp | 2024-12-31 | 40.8 K | Blackrock Inc | 2024-12-31 | 40.6 K | Fermata Advisors, Llc | 2024-12-31 | 35.7 K | Virtu Financial Llc | 2024-12-31 | 28.5 K | Laird Norton Tyee Trust Co | 2024-12-31 | 25 K | Jane Street Group Llc | 2024-12-31 | 18.5 K | Kingdon Capital Management Llc | 2024-12-31 | 859.3 K | Nantahala Capital Management, Llc | 2024-12-31 | 596.9 K |
EnVVeno Medical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 7.2M | 45.4M | (50.2M) | (935K) | (841.5K) | (799.4K) | |
| Free Cash Flow | (7.9M) | (12.2M) | (15.7M) | (18.9M) | (17.0M) | (16.2M) | |
| Depreciation | 384.0K | 452.9K | 525K | 546K | 627.9K | 348.8K | |
| Other Non Cash Items | (288.7K) | (312.6K) | (339K) | (468K) | (421.2K) | (400.1K) | |
| Capital Expenditures | 180.3K | 367.9K | 115K | 33K | 38.0K | 36.1K | |
| Net Income | (9.1M) | (16.5M) | (24.7M) | (23.5M) | (21.2M) | (20.1M) | |
| End Period Cash Flow | 9.3M | 54.7M | 4.6M | 3.6M | 4.2M | 4.0M | |
| Investments | (180.3K) | (367.9K) | (34.4M) | 19.8M | 17.8M | 18.7M | |
| Change To Netincome | 1.5M | 697.2K | 5.7M | 9.1M | 10.4M | 10.9M |
EnVVeno Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EnVVeno Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EnVVeno Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EnVVeno stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.86 | |
σ | Overall volatility | 4.06 | |
Ir | Information ratio | 0.01 |
EnVVeno Medical Volatility Alert
enVVeno Medical Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.01 and Jensen Alpha of 0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EnVVeno Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EnVVeno Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.EnVVeno Medical Fundamentals Vs Peers
Comparing EnVVeno Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EnVVeno Medical's direct or indirect competition across all of the common fundamentals between EnVVeno Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as EnVVeno Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EnVVeno Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing EnVVeno Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare EnVVeno Medical to competition |
| Fundamentals | EnVVeno Medical | Peer Average |
| Return On Equity | -0.59 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Current Valuation | 13.97 M | 16.62 B |
| Shares Outstanding | 17.54 M | 571.82 M |
| Shares Owned By Insiders | 0.80 % | 10.09 % |
| Shares Owned By Institutions | 24.37 % | 39.21 % |
| Number Of Shares Shorted | 433.03 K | 4.71 M |
| Price To Book | 1.29 X | 9.51 X |
| EBITDA | (25.02 M) | 3.9 B |
| Net Income | (23.52 M) | 570.98 M |
| Cash And Equivalents | 37.48 M | 2.7 B |
| Cash Per Share | 3.96 X | 5.01 X |
| Total Debt | 1.4 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 20.79 X | 2.16 X |
| Book Value Per Share | 2.70 X | 1.93 K |
| Cash Flow From Operations | (18.86 M) | 971.22 M |
| Short Ratio | 3.58 X | 4.00 X |
| Earnings Per Share | (1.29) X | 3.12 X |
| Target Price | 16.5 | |
| Number Of Employees | 31 | 18.84 K |
| Beta | 1.23 | -0.15 |
| Market Capitalization | 61.9 M | 19.03 B |
| Total Asset | 48.63 M | 29.47 B |
| Retained Earnings | (130.04 M) | 9.33 B |
| Working Capital | 45.55 M | 1.48 B |
| Net Asset | 48.63 M |
Note: Acquisition by Gray Robert of 3500 shares of EnVVeno Medical at 2.94 subject to Rule 16b-3 [view details]
EnVVeno Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EnVVeno . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About EnVVeno Medical Buy or Sell Advice
When is the right time to buy or sell enVVeno Medical Corp? Buying financial instruments such as EnVVeno Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having EnVVeno Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Check out EnVVeno Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.